Physician profile
Steven Mark Schiff
NPI 1245368265
$2,589.68
in general payments reported to CMS, 2019-2025
18 companies · $179 in 2025
The $179 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,505 · 2020: $266 · 2021: $269 · 2022: $351 · 2023: $19.86 · 2025: $179.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $199.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $198.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Silk Road Medical, INC. | $957.32 | 2019 | |
| Abbott Laboratories | $403.87 | 2021-2025 | Amplatzer Talisman, Amplatzer Amulet |
| Sanofi-Aventis U.S. LLC | $212.36 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $167.06 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $139.23 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $121.41 | 2019-2022 | |
| Medtronic Vascular, INC. | $105.11 | 2020 | |
| Biotronik INC. | $103.42 | 2021 | |
| Pfizer INC. | $97.15 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $75.78 | 2019-2021 | |
| Astellas Pharma US INC | $73.32 | 2019 | |
| Edwards Lifesciences Corporation | $34.06 | 2019 | |
| Amgen INC. | $20.72 | 2020 | |
| Lundbeck LLC | $19.05 | 2019 | |
| Boston Scientific Corporation | $18.49 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $15.08 | 2021 | |
| Medtronic, INC. | $13.63 | 2022 | |
| Amarin Pharma, INC. | $12.62 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Schiff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.